文献速递急性肾损伤慢性肾脏病

SPRINT试验提示尿液肾小管功能标志物与后续急性肾损伤风险相关,而损伤标志物在损伤后升高

The SPRINT trial suggests that markers of tubule cell function in the urine associate with risk of subsequent acute kidney injury while injury markers elevate after the injury.
PubMed 文献 · Kidney Int · 2019-05-07

在SPRINT试验中eGFR低于60 ml/min/1.73m2的2351例参与者中,基线尿uromodulin较低和α1m较高与后续急性肾损伤(AKI)风险独立相关,而五种损伤标志物均与AKI无关联。在947例重复测量亚组中,发生AKI者随访时尿NGAL、IL-18和YKL-40及α1m升高。

要点

  • 基线尿uromodulin较低和α1m较高与后续AKI风险独立相关。
  • 五种尿损伤标志物基线水平均与后续AKI无关联。
  • 发生AKI后尿NGAL、IL-18、YKL-40和α1m纵向升高。

核心结论

  • 联合评估肾小管功能与损伤标志物可揭示AKI易感因素及损伤后反应。
  • 基线肾小管功能障碍标志物与后续AKI风险相关,而损伤标志物在AKI后升高。

研究设计与样本

  • SPRINT试验中eGFR低于60 ml/min/1.73m2的2351例参与者,基线测量尿肾小管功能与损伤标志物。
  • 采用Cox模型评估标志物与后续AKI风险的关联,并校正临床危险因素、基线eGFR和白蛋白尿。
  • 在947例随机亚组中于4年后重复测量生物标志物,比较有无间发AKI者的变化。

主要发现

  • 平均随访3.8年期间184例发生AKI。
  • uromodulin每升高两倍的风险比为0.68(95%CI 0.56-0.83),α1m为1.20(95%CI 1.01-1.44),均独立于eGFR和白蛋白尿。
  • 五种损伤标志物(NGAL、KIM-1、IL-18、MCP-1、YKL-40)基线水平均与后续AKI无关联。
  • 重复测量亚组中59例发生间发AKI者尿NGAL、IL-18、YKL-40和α1m纵向升高。

临床怎么用

  • 在CKD患者中可考虑检测尿uromodulin和α1m以评估AKI易感性。
  • 尿损伤标志物升高可能反映AKI后肾小管损伤反应,而非预测AKI。

局限性

  • 研究限于eGFR低于60 ml/min/1.73m2的SPRINT参与者,外推需谨慎。
  • 重复测量亚组为随机子集,样本量有限。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Urine markers can quantify tubular function including reabsorption (α-1 microglobulin [α1m]) and β-2-microglobulin [β2m]) and protein synthesis (uromodulin). Individuals with tubular dysfunction may be less able to compensate to insults than those without, despite similar estimated glomerular filtration rate (eGFR) and albuminuria. Among Systolic Blood Pressure Intervention Trial (SPRINT) participants with an eGFR under 60 ml/min/1.73m2, we measured urine markers of tubular function and injury (neutrophil gelatinase-associated lipocalin [NGAL], kidney injury molecule-1 [KIM-1], interleukin-18 [IL-18], monocyte chemoattractant protein-1, and chitinase-3-like protein [YKL-40]) at baseline. Cox models evaluated associations with subsequent acute kidney injury (AKI) risk, adjusting for clinical risk factors, baseline eGFR and albuminuria, and the tubular function and injury markers. In a random subset, we remeasured biomarkers after four years, and compared changes in biomarkers in those with and without intervening AKI. Among 2351 participants, 184 experienced AKI during 3.8 years mean follow-up. Lower uromodulin (hazard ratio per two-fold higher (0.68, 95% confidence interval [0.56, 0.83]) and higher α1m (1.20; [1.01, 1.44]) were associated with subsequent AKI, independent of eGFR and albuminuria. None of the five injury markers were associated with eventual AKI. In the random subset of 947 patients with repeated measurements, the 59 patients with intervening AKI versus without had longitudinal increases in urine NGAL, IL-19, and YKL-40 and only 1 marker of tubule function (α1m). Thus, joint evaluation of tubule function and injury provided novel insights to factors predisposing to AKI, and responses to kidney injury.

来源:Kidney Int,查看原文。版权归原作者所有。

引用

  1. Bullen AL, Katz R, Lee AK, et al. The SPRINT trial suggests that markers of tubule cell function in the urine associate with risk of subsequent acute kidney injury while injury markers elevate after the injury. Kidney Int. 2019. PMID: 31262489. doi:10.1016/j.kint.2019.03.024

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。